Lexicon Pharmaceuticals
LXRX
#7142
Rank
C$0.70 B
Marketcap
C$1.93
Share price
-1.41%
Change (1 day)
112.21%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total debt

Total debt on the balance sheet as of September 2025 : C$80.33 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is C$80.33 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Lexicon Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$0.15 B10.57%
2023-12-31C$0.14 B87.49%
2022-12-31C$75.03 M2483.32%
2021-12-31C$2.9 M-82.22%
2020-12-31C$16.33 M-94.91%
2019-12-31C$0.32 B-3.83%
2018-12-31C$0.33 B8.05%
2017-12-31C$0.30 B126.56%
2016-12-31C$0.13 B-4.53%
2015-12-31C$0.14 B14.28%
2014-12-31C$0.12 B436.52%
2013-12-31C$23.28 M-0.14%
2012-12-31C$23.31 M-7.91%
2011-12-31C$25.32 M-11.06%
2010-12-31C$28.47 M-59.59%
2009-12-31C$70.45 M90.04%
2008-12-31C$37.07 M18.46%
2007-12-31C$31.29 M-16.49%
2006-12-31C$37.47 M-12.86%
2005-12-31C$43 M-4.85%
2004-12-31C$45.19 M-38.16%
2003-12-31C$73.08 M1056.92%
2002-12-31C$6.31 M
2000-12-31C$4.26 M-38.13%
1999-12-31C$6.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
C$0.76 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$3.73 B 4,552.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$46.74 M-41.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.83 B 939.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$49.29 B 61,258.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.42 B 427.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$3.55 B 4,329.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.62 B 675.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.46 B 479.51%๐Ÿ‡บ๐Ÿ‡ธ USA